Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 28;52(10):3424-7.
doi: 10.1021/jm900451y.

Replacement of a thiourea-S with an amidine-NH donor group in a platinum-acridine antitumor compound reduces the metal's reactivity with cysteine sulfur

Affiliations

Replacement of a thiourea-S with an amidine-NH donor group in a platinum-acridine antitumor compound reduces the metal's reactivity with cysteine sulfur

Zhidong Ma et al. J Med Chem. .

Abstract

The reactivity of two DNA-targeted platinum-acridine conjugates with cysteine sulfur was studied. The conjugate containing an amidine-NH donor group cis to the chloride leaving group showed considerably reduced reactivity with N-acetylcysteine compared to the prototypical derivative containing a thiourea-S linkage. The opposite scenario has been observed previously in reactions with nucleobase nitrogen. Possible consequences of the unique target-selective tuning of the substitution chemistry for the pharmacodynamic properties and biological activity of these agents are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of compound 1 and PT-ACRAMTU (2) with structural differences highlighted.
Figure 2
Figure 2
Progress of the reactions of compound 1 (open circles) and compound 2 (filled circles) with one equivalent of N-acetylcysteine (N-AcCys) at 25 °C monitored by 1H NMR spectroscopy. The data shown is the mean of two experiments. The solid line (for 1) represents a curve fit assuming second-order conditions, [Pt]/[Pt]0 = (1 + k [Pt]0 t)−1; (t1/2 = 180 min). The dashed trend line (for 2) has no physical significance.
Figure 3
Figure 3
Positive-ion electrospray mass spectra of adducts I (A) and II (B) showing peaks for the molecular ions, [I]+ (m/z 725.2) and [II-2H]2+ (m/z 643.7, z = 2), and fragment ions resulting from in-source collisionally activated dissociation (CAD). The insets illustrate the observed fragmentation patterns. The discrepancy between the calculated and observed m/z values for some of the platinum containing ions is due to distorted Pt isotope patterns.
Scheme 1
Scheme 1
Reactivity of Compounds 1 and 2 with N-Acetylcysteine (N-AcCys)

Similar articles

Cited by

References

    1. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 2007;334:115–124. - PubMed
    1. Wang X, Guo Z. The role of sulfur in platinum anticancer chemotherapy. Anticancer Agents Med. Chem. 2007;7:19–34. - PubMed
    1. Holford J, Sharp SY, Murrer BA, Abrams M, Kelland LR. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. Br. J. Cancer. 1998;77:366–373. - PMC - PubMed
    1. Beale P, Judson I, O'Donnell A, Trigo J, Rees C, Raynaud F, Turner A, Simmons L, Etterley L. A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine)platinum(II) (AMD473). Br. J. Cancer. 2003;88:1128–1134. - PMC - PubMed
    1. Barnham KJ, Djuran MI, Murdoch PS, Ranford JD, Sadler PJ. Ring-Opened Adducts of the Anticancer Drug Carboplatin with Sulfur Amino Acids. Inorg. Chem. 1996;35:1065–1072. - PubMed

Publication types

MeSH terms